Purple Biotech Plans To Change Ratio Of ADS To Ordinary Shares To ADS Ratio Of 1 ADS Representing 200 Ordinary Shares
Portfolio Pulse from Benzinga Newsdesk
Purple Biotech has announced plans to change the ratio of its American Depositary Shares (ADS) to ordinary shares, with the new ratio being 1 ADS representing 200 ordinary shares. This change is detailed in a recent SEC filing.
September 11, 2024 | 8:20 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Purple Biotech is adjusting its ADS to ordinary shares ratio to 1:200. This change could affect the liquidity and trading dynamics of its ADS on the market.
The change in ADS to ordinary shares ratio can influence the stock's liquidity and market perception. However, without additional context on the reasons behind the change or market conditions, the short-term price impact is uncertain.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100